BRIEF: Leading RNA drug developer Ribo passes Hong Kong listing hearing, kicking off IPO
Leading RNA drug developer Suzhou Ribo Life Science Co. Ltd. passed its hearing for a listing on the Hong Kong Stock Exchange, marking the official launch of its IPO, according…
